Emerging Biomarkers and Advanced Imaging in Cardiovascular Risk Stratification: From Cancer Survivors to Acute Coronary Syndromes
Year: 2026
Type: article
Abstract: Background: Conventional cardiac risk models repeatedly failed to acquire the dynamic disease processes like treatment-associated cardiotoxicity and injury post reperfusion. This review aims to assess the clinical utilization of emerging biomarkers and latest imaging tactics to improvise risk stratification especially for patients with acute coronary syndrome and cancer survivors. Methods: We conducted a targeted literature search across available databases like PubMed, Science Direct and Google Scholar, specifically for studies between 2015-2025. High quality reviews, Randomized trials and large cohort studies were prioritized containing research linked between biomarkers like high sensitivity-cardiac Troponin, and Trimethylamine N-Oxide; advanced imaging modalities like Global Longitudinal Strain and Cardiac Magnetic Resonance; as well as major cardiac outcomes. Results: The incorporation of multi-modality evaluation substantially improves diagnostic accuracy compared to traditional approaches. High sensitivity cardiac troponins and natriuretic peptides persist foundationally for identifying early subclinical injury, whereas novel biomarkers like soluble suppression of tumorigenicity 2 and Galectin-3 provide greater prognostic value concerning fibrosis and detrimental remodeling. Microbiome-derived metabolites like Trimethylamine N-Oxide, offer independent prognosis of Major adverse Cardiovascular events via associating gut dysbiosis to vascular inflammation. Imaging techniques like Global Longitudinal Strain recognizes ventricular malfunction prior to Left Ventricular Ejection Fraction decline, thus providing a crucial window for Cardioprotective manipulation in cardio-oncology. However, Cardiac Magnetic resonance remains the gold standard in identifying microvascular obstruction and infarct size. Conclusion: Newly surfacing biomarkers and modern imaging techniques ensure for more tailored risk stratification. In spite of various barriers in standardizing and cost, fostering a multi-biomarker strategy with integration of artificial intelligence is critical for enhancing long term outcomes in high-risk patients like cancer survivors and patients with acute coronary syndrome.
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Keywords: cardiovascular risk stratification, cancer survivors, acute coronary syndrome, cardiac biomarkers, high-sensitivity troponin, trimethylamine N-oxide, soluble ST2, galectin-3, natriuretic peptides, global longitudinal strain, cardiac magnetic resonance, cardio-oncology, myocardial fibrosis, major adverse cardiovascular events, gut dysbiosis, artificial intelligence
Open Access status: diamond
OpenAlex ID: W7220253471
